Development of a biomarker mortality risk model in acute respiratory distress syndrome
Abstract Background There is a compelling unmet medical need for biomarker-based models to risk-stratify patients with acute respiratory distress syndrome. Effective stratification would optimize participant selection for clinical trial enrollment by focusing on those most likely to benefit from new...
Main Authors: | Christian Bime, Nancy Casanova, Radu C. Oita, Juliet Ndukum, Heather Lynn, Sara M. Camp, Yves Lussier, Ivo Abraham, Darrick Carter, Edmund J. Miller, Armand Mekontso-Dessap, Charles A. Downs, Joe G. N. Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-12-01
|
Series: | Critical Care |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13054-019-2697-x |
Similar Items
-
Circulating eNAMPT as a biomarker in the critically ill: acute pancreatitis, sepsis, trauma, and acute respiratory distress syndrome
by: Christian Bime, et al.
Published: (2022-06-01) -
Elastance-derived transpulmonary pressure may overestimate the risk of overdistension in severely obese patients
by: Samuel Tuffet, et al.
Published: (2023-05-01) -
Understanding the role of neutrophils in acute respiratory distress syndrome
by: Shun-Chin Yang, et al.
Published: (2021-08-01) -
Impact of cardiac output and alveolar ventilation in estimating ventilation/perfusion mismatch in ARDS using electrical impedance tomography
by: Samuel Tuffet, et al.
Published: (2023-05-01) -
Efficacy and safety of argatroban in patients with acute respiratory distress syndrome and extracorporeal lung support
by: Mario Menk, et al.
Published: (2017-08-01)